delphine BAETZ

Dr. delphine BAETZ

1. Univ-Lyon, CarMeN Laboratory, INSERM 1060, INRA 1397, Université Claude Bernard Lyon1, INSA Lyon, Oullins, France
+1
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
TBT. Bochaton
T. Bochaton
CCC. Crola-Da-Silva
C. Crola-Da-Silva
BPB. Pillot
B. Pillot
CVC. Villedieu
C. Villedieu
LFL. Ferreras
L. Ferreras
DBdelphine BAETZ
delphine BAETZ

1 January 2015 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
MAMuhammad Rizwan Alam
Muhammad Rizwan Alam
DBdelphine BAETZ
delphine BAETZ
MOMichel Ovize
Michel Ovize

13 December 2005 in Circulation
Verified
Journal Article
Closed access
PDF file
DBdelphine BAETZ
delphine BAETZ
KRKelly M. Regula
Kelly M. Regula
KEKaren Ens
Karen Ens
JSJames Shaw
James Shaw
SKShilpa Kothari
Shilpa Kothari
LKLorrie A. Kirshenbaum
Lorrie A. Kirshenbaum
Background— A survival role for the transcription factor nuclear factor-κB (NF-κB) in ventricular myocytes has been reported; however, the underlying mechanism is undefined. In this report we provide new mechanistic evidence that survival signals conferred by NF-κB impinge on the hypoxia-inducible death factor BNIP3. Methods and Results— Activation of the NF-κB signaling pathway by IKKβ in ventricular myocytes suppressed mitochondrial permeability transition pore (PTP) opening and cell death provoked by BNIP3. Expression of IKKβ or p65 NF-κB suppressed basal and hypoxia-inducible BNIP3 gene activity. Deletion analysis of the BNIP3 promoter revealed the NF-κB elements to be crucial for inhibiting basal and inducible BNIP3 gene activity. Cells derived from p65 −/− -deficient mice or ventricular myocytes rendered defective for NF-κB signaling with a nonphosphorylative IκB exhibited increased basal BNIP3 gene expression, mitochondrial PTP, and cell death. Genetic or functional ablation of the BNIP3 gene in NF-κB–defective myocytes rescued them from mitochondrial defects and cell death. Conclusions— The data provide new compelling evidence that NF-κB suppresses mitochondrial defects and cell death of ventricular myocytes through a mechanism that transcriptionally silences the death gene BNIP3. Collectively, our data provide new mechanistic insight into the mode by which NF-κB suppresses cell death and identify BNIP3 as a key transcriptional target for NF-κB–regulated expression in ventricular myocytes.

11 April 2007 in Diabetologia
Verified
Journal Article
Closed access
PDF file
ADA. Darmellah
A. Darmellah
DBdelphine BAETZ
delphine BAETZ
FPF. Prunier
F. Prunier
STS. Tamareille
S. Tamareille
CRCatherine Rucker-Martin
Catherine Rucker-Martin
DFD. Feuvray
D. Feuvray

8 December 2006 in Circulation Research
Verified
Journal Article
Closed access
PDF file
JSJames Shaw
James Shaw
TZTong Zhang
Tong Zhang
MRMarek Rzeszutek
Marek Rzeszutek
NYNatalia Yurkova
Natalia Yurkova
DBdelphine BAETZ
delphine BAETZ
Lorrie KirshenbaumLorrie Kirshenbaum
Lorrie Kirshenbaum
Earlier we identified a survival role for NF-κB in ventricular myocytes, however, the underlying mechanism was undefined. In this report we provide new mechanistic evidence that the hypoxia-inducible death factor BNIP3 is transcriptionally silenced by NF-κB through a mechanism that involves the cooperative actions of HDAC1. Activation of the NF-κB signaling pathway in ventricular myocytes suppressed basal and hypoxia-inducible BNIP3 gene activity. Basal Bnip3 gene expression was increased in cells derived from p65 −/− deficient mice. The histone deacetylase (HDAC) inhibitor Trichostatin A (TSA 10 nM) suppressed the inhibitory actions of NF-κB on Bnip3 gene transcription. Basal and hypoxia- induced Bnip3 transcription was repressed by wild type but not a catalytically inactive mutant of HDAC1. Immunoprecipitation assays verified interaction of HDAC1 with wild type p65 NF-κB and mutations of p65 defective for transactivation in ventricular myocytes. Deletion analysis revealed canonical NF-κB elements within the Bnip3 promoter to be important for repression of Bnip3 gene expression by HDAC1. Further, the ability of HDAC1 to repress Bnip3 gene transcription was lost in cells derived from p65 −/− deficient mice but was restored by repletion of p65 NF-κB into p65 −/− cells. Mutations of p65 NF-κB defective for DNA binding but not for transactivation abrogated the inhibitory actions of HDAC1 on the Bnip3 gene transcription. Together, our findings provide new mechanistic insight into the cytoprotective actions conferred by NF-κB that extend to the active transcriptional repression of the death factor Bnip3 through a mechanism that is mutually dependent on HDAC-1.

1 June 2006 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Open access
PDF file
Sabzali JavadovSabzali Javadov
Sabzali Javadov
DBdelphine BAETZ
delphine BAETZ
VRVenkatesh Rajapurohitam
Venkatesh Rajapurohitam
AZAsad Zeidan
Asad Zeidan
LKLorrie A. Kirshenbaum
Lorrie A. Kirshenbaum
MKMorris Karmazyn
Morris Karmazyn
Although inhibition of Na+/H+ exchanger isoform 1 (NHE-1) reduces cardiomyocyte hypertrophy, the mechanisms underlying this effect are not known. Recent evidence suggests that this may be associated with improved mitochondrial function. To understand the mechanistic bases for mitochondrial involvement in the antihypertrophic effect of NHE-1 inhibition, we examined the effect of the NHE-1-specific inhibitor N-[2-methyl-4,5-bis(methylsulphonyl)-benzoyl]-guanidine, hydrochloride (EMD, EMD87580; 5 μM) on the hypertrophic phenotype, mitogen-activated protein kinase (MAPK) activity, mitochondrial membrane potential (Δψm), permeability transition (MPT) pore opening, and superoxide generation in phenylephrine (PE)-treated neonatal rat cardiomyocytes. EMD significantly suppressed markers of cell hypertrophy, including cell surface area and gene expression of atrial natriuretic peptide and α-skeletal actin. EMD inhibited the PE-induced MPT pore opening, prevented the loss in Δψm, and attenuated superoxide generation induced by PE. Moreover, the activation of p38 MAPK (p38) and extracellular signal-regulated kinase (ERK) 1/2 MAPKs induced by PE was significantly attenuated in the presence of EMD as well as the antioxidant catalase. To examine the role of MPT and mitochondrial Ca2+ uniport in parallel with EMD, the effects of cyclosporin A (0.2 μM) and ruthenium red (10 μM) were evaluated. Both agents significantly attenuated PE-induced hypertrophy and inhibited both mitochondrial dysfunction and p38 and ERK1/2 MAPK activation. Our results suggest a novel mechanism for attenuation of the hypertrophic phenotype by NHE-1 inhibition that is mediated by a reduction in PE-induced MAPK activation and superoxide production secondary to improved mitochondrial integrity.